Avoid Warning Letters in View of the U.S. FDA`s Stated Goal 2015 is an event that provides knowledge on avoid warning letters in view of the US FDA`s stated goal.
Avoid Warning Letters in View of the U.S. FDA`s Stated Goal 2015 covers topics such as:
- Proactive reviews of the applicable U.S. FDA / cGMP requirements
- The U.S. FDA`s new aggressive implementation plans
- FDA Inspectional Objectives
- Key areas to focus limited resources
- Recent trends and events
- Common areas for critical mistakes
- Q&A
- The compliance audit
Avoid Warning Letters in View of the U.S. FDA`s Stated Goal 2015 is intended for:
- Regulatory Affairs
- Senior Management, Project Leaders
- Internal and Supplier Auditor Personnel
- Quality Systems Personnel
- CAPA and P&PC personnel desiring to optimize systems and responses in harmony with the U.S. FDA`s quality management systems / cGMP expectations
- R&D and Engineering Staff
